Sandhu Sarbjinder S, Symes Andrew, A'Hern Roger, Sohaib S A Aslam, Eisen Tim, Gore Martin, Christmas Timothy J
The Royal Marsden Hospital, London, UK.
BJU Int. 2005 Mar;95(4):522-5. doi: 10.1111/j.1464-410X.2005.05331.x.
To present our results on managing loco-regional recurrence of renal cell carcinoma (RCC) with surgical excision, as local recurrence at the site of a previous nephrectomy is resistant to both systemic therapy and radiotherapy.
In all, 16 patients were operated on between 1994 and 2003 for local recurrence of RCC. The median (mean, range) age at the time of local recurrence was 57.9 (57.4, 28.9-71.7) years, and the median interval from primary surgery 2.22 (3.88, 0.27-14.46) years. Before surgery eight patients had been given systemic immunotherapy, with no response of their local recurrence.
Two patients were deemed inoperable because of direct invasion of the great vessels and the liver by tumour. The remaining 14 patients had recurrence in residual adrenal tissue (two), para-aortic nodes (three), para-caval nodes (two), retrocaval nodes (one), renal bed (six), liver, spleen and stomach (one each), and diaphragm (two). Although complete macroscopic en-bloc clearance was achieved in these patients, only eight had tumour-free margins on histological examination. The histology was consistent with RCC recurrence in all cases. All of the patients were followed with computed tomography at regular intervals. At a median follow-up of 1.0 (1.65, 0.25-6.5) years, five patients remain disease-free, four have local and distant relapse, and five developed distant metastasis only. The presence of tumour at the resection margin was a significant factor in predicting local and distant disease-free survival (P < 0.05).
En bloc excision of isolated locally recurrent RCC is possible, and complete surgical extirpation can lead to prolonged disease-free survival.
介绍我们采用手术切除治疗肾细胞癌(RCC)局部区域复发的结果,因为既往肾切除部位的局部复发对全身治疗和放疗均耐药。
1994年至2003年间,共有16例患者因RCC局部复发接受手术治疗。局部复发时的中位(平均,范围)年龄为57.9(57.4,28.9 - 71.7)岁,距初次手术的中位间隔时间为2.22(3.88,0.27 - 14.46)年。术前8例患者接受过全身免疫治疗,但其局部复发无缓解。
2例患者因肿瘤直接侵犯大血管和肝脏而被认为无法手术。其余14例患者的复发部位为残留肾上腺组织(2例)、主动脉旁淋巴结(3例)、腔静脉旁淋巴结(2例)、腔静脉后淋巴结(1例)、肾床(6例)、肝脏、脾脏和胃(各1例)以及膈肌(2例)。尽管这些患者实现了完整的宏观整块切除,但组织学检查时只有8例切缘无肿瘤。所有病例的组织学表现均符合RCC复发。所有患者均定期接受计算机断层扫描随访。中位随访1.0(1.65,0.25 - 6.5)年时,5例患者无疾病复发,4例出现局部和远处复发,5例仅发生远处转移。切缘有肿瘤是预测局部和远处无病生存的重要因素(P < 0.05)。
孤立性局部复发性RCC行整块切除是可行的,完整的手术切除可延长无病生存期。